3Q Revenues: $203.7 million (+18%)
3Q Earnings: $15.5 million (earnings were $0.4 million in 3Q11)
YTD Revenues: $539.1 million (+4%)
YTD Loss: $83.5 million (loss of $6.5 million YTD11)
Comments: Commercial manufacturing revenues in the quarter were up 21% to $168.3 million. Pharmaceutical Development Services' revenues were up 4% to $35.4 million. Growth in the quarter was driven by growth in existing business and supported by the company’s restructuring initiatives.